UNSPSC 51201608: Influenza virus vaccine

This classification denotes a vaccine for an acute viral infection in humans involving the respiratory tract. It is marked by inflammation of the nasal mucosa; the pharynx; and conjunctiva, and by headache and severe, often generalized, myalgia.

UNSPSC 51201608 Influenza virus vaccine is a Commodity code under which state and local health departments procure vaccines for routine immunization programs and disease prevention initiatives. Recent state and local activity under this code shows purchasing for viral vaccines beyond the narrow scope of the code name — the Mississippi State Department of Health's recent sole source notice, for example, targets yellow fever vaccine from a single qualified supplier rather than influenza-specific products. State health departments emerge as the primary issuing bodies soliciting under this code, reflecting centralized procurement authority for population-level immunization programs and outbreak response.

The Mississippi State Department of Health posted a sole source procurement notice (Number 1301-27-R-RFIN-00001) on July 13, 2026, with an objection deadline of August 3, 2026, for yellow fever vaccine from Sanofi Pasteur, Inc. The notice does not specify quantity, contract term, estimated value, or pricing. The source contains a single recent opportunity; geographic activity is limited to Mississippi as reported here. State and local procurement of vaccines under this code typically routes through state health department purchasing offices and may also involve cooperative purchasing arrangements with county and local health authorities, though the recent opportunities block does not confirm current multi-jurisdictional purchasing patterns.